Arvinas, INC Form 4 insider transactions

Arvinas, Inc. Director Laurie Smaldone Alsup was granted stock options and restricted stock units on June 24, 2026, with vesting conditions tied to service and annual meetings.

Arvinas, Inc. reports that Director Leslie V. Norwalk acquired 15,527 shares of common stock and was granted options for 22,714 shares.

Arvinas, Inc. Director Briggs Morrison acquired 15,527 shares of common stock and was granted 22,714 stock options, as detailed in a Form 4 filing.

Arvinas Director Edward Moore Kennedy Jr. was granted stock options and restricted stock units on June 24, 2026, with vesting contingent on continued service.

Arvinas, Inc. Director Everett Cunningham was granted stock options and restricted stock units on June 24, 2026, with vesting conditions tied to continued service.

Arvinas, Inc. Director Linda Bain acquired restricted stock units and stock options on June 24, 2026, as detailed in a Form 4 filing.

Arvinas Chief Financial Officer Andrew Saik sold 5,696 shares of common stock to cover tax withholding obligations related to restricted stock units.

Arvinas Chief Scientific Officer Angela M. Cacace sold 2,576 shares of common stock to cover tax withholding obligations related to restricted stock units.

Arvinas, Inc. VP, Chief Accounting Officer David K. Loomis sold 1,919 shares of common stock to cover tax withholding obligations.

Arvinas Chief Scientific Officer Angela M. Cacace sold 9,657 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Arvinas Chief Medical Officer Noah Berkowitz sold 6,435 shares of common stock to cover tax withholding obligations related to RSU vesting.

An amended SEC filing corrects the number of restricted stock units granted to Arvinas President and CEO Randy Teel, reducing the reported amount.

ARVINAS's VP, Chief Accounting Officer, David K Loomis, received grants of restricted stock units and stock options as part of the company's incentive plan.

Arvinas' Chief Scientific Officer, Angela M. Cacace, received a grant of 45,000 restricted stock units and options to purchase 67,000 shares of common stock.

Arvinas Chief Medical Officer Noah Berkowitz received substantial equity awards, including restricted stock units and stock options, as part of the company's incentive plan.

ARVINAS, Inc. Chief Financial Officer Andrew Saik was granted 45,000 restricted stock units and 67,000 stock options as part of his compensation.

Arvinas, Inc. President and CEO Randy Teel received significant equity awards, including 147,791 restricted stock units and options for 218,691 shares, as part of the company's 2018 Stock Incentive Plan.

Arvinas Director John G. Houston sold 35,297 shares for $466,247 to cover tax obligations from RSU vesting, a routine non-discretionary transaction.

Arvinas Chief Accounting Officer David K. Loomis sold 1,108 shares of common stock to cover tax withholding obligations related to RSU vesting.

Arvinas Chief Scientific Officer Angela M. Cacace sold shares of common stock to cover tax withholding obligations related to RSU vesting.

Arvinas President and CEO Randy Teel sold 4,786 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Arvinas Chief Accounting Officer David K. Loomis sold 230 shares of common stock at $9.89 per share to cover tax withholding obligations related to RSU vesting.

Arvinas Director Briggs Morrison acquired 30,000 shares of common stock at a weighted average price of $7.567 per share.

Arvinas, Inc. Director Sunil Agarwal was granted 16,025 restricted stock units and 23,105 stock options as part of his compensation, aligning his interests with shareholder value.

Arvinas, Inc. Director Laurie Smaldone Alsup was granted 16,025 restricted stock units and 23,105 stock options, aligning her interests with shareholders.

Arvinas, Inc. Director Briggs Morrison was granted 16,025 restricted stock units and 23,105 stock options on June 25, 2025, as part of his compensation.

Arvinas, Inc. Director John D. Young was granted 16,025 restricted stock units and 23,105 stock options, aligning his interests with shareholders.

Arvinas, Inc. Director Linda Bain was granted 16,025 restricted stock units and 23,105 stock options as part of her compensation, aligning her interests with shareholders.

Arvinas, Inc. Director Edward Moore Kennedy Jr. was granted 16,025 restricted stock units and 23,105 stock options, aligning his interests with shareholders.

Arvinas, Inc. Director Everett Cunningham was granted 16,025 Restricted Stock Units and 23,105 Stock Options on June 25, 2025, as part of his compensation.